Copenhagen Bioscience Lecture - Metabolite Signaling, Receptors and Novel Drugs
The Copenhagen Bioscience Lectures are a series of open lectures for all researchers and other interested in and around the Copenhagen area. Every 4 weeks, on a Thursday evening, you are invited for lectures on themes with a general interest for the Novo Nordisk Foundation Research Centers and bioscience researchers in general. Often there will be a cross-disciplinary focus. The lecture on the 17th of May 2018 features professor Thue Schwartz and associate professor Thomas Frimurer from the Section for Metabolic Receptology at the Novo Nordisk Foundation Center for Basic Metabolic Research. Based on their background in molecular pharmacology and extensive collaborations and research alliances with biotech and pharmaceutical companies as well as academic medicinal chemistry groups, pharmacological tool compounds and drug candidates constitute key elements of their research which covers from basic in vitro signal transduction over a large number of ex vivo models to in vivo models including a large number of genetic models. They believe that metabolite GPCRs constitute a highly interesting almost untapped pharmacotherapeutic potential through which novel means to control metabolic and endocrine cell function, and importantly to address metabolic inflammation to treat obesity and type 2 diabetes, can be developed.
Read more
Facts
Programme
